Apogee Therapeutics Inc (APGE) PT Raised to $120 at Jefferies
Jefferies analyst Akash Tewari raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $120.00 (from $100.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
